Menu

Prominent Salk Institute Scientist Inder Verma Resigns

His decision came as an investigation into sexual harassment allegations against him was ongoing.  

Jun 12, 2018
Sukanya Charuchandra

The Salk Institute of Biological StudiesISTOCK, DOUGBERRYInder Verma, a leading cancer researcher at the Salk Institute for Biological Studies, resigned on June 6 during an investigation into sexual harassment allegations against him, reports Science. In a letter on June 11, Dan Lewis, the chair of the Board of Trustees and Rusty Gage, the president of the Institute, say the Board unanimously accepted Verma’s “unconditional resignation,” calling it an “appropriate responsive action,” without offering any specifics of the investigation.

According to Science, Salk hired The Rose Group, a law firm, to investigate the case against Verma in March. Following Science’s April reporting of sexual misconduct allegations by eight women with connections to the institute, Verma was placed on administrative leave. This was in addition to his suspension as PNAS’s editor-in-chief after a gender discrimination lawsuit was filed against the Salk Institute.

Verma claims he has never misbehaved, reports The San Diego Union-Tribune. In an email to the newspaper in April, he said, “I have never used my position at the Salk Institute to take advantage of others.” He went on to add, “I have also never engaged in any sort of intimate relationship with anyone affiliated with the Salk Institute.”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.